Article
A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation.
Cell reports methods - 22 Apr 2024
Bao Chaohui, Tan Tingting, Wang Shan, Gao Chenxu, Lu Chang, Yang Siyue, Diao Yizhu, Jiang Lulu, Jing Duohui, Chen Liye, Lv Haitao, Fang Hai
Abstract excerpt
Cross-disease genome-wide association studies (GWASs) unveil pleiotropic loci, mostly situated within the non-coding genome, each of which exerts pleiotropic effects across multiple diseases. However, the challenge "W-H-W" (namely, whether, how, and in which specific diseases pleiotropy can inform clinical therapeutics) calls for effective and integrative approaches and tools. We here introduce a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
